Trial Profile
AZILECT Tablets Special Drug Use-Results Survey "Survey on Long-term Safety"
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Mar 2024
Price :
$35
*
At a glance
- Drugs Rasagiline (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Sponsors Takeda
- 02 Nov 2021 Status changed from active, no longer recruiting to completed.
- 01 Dec 2020 Status changed from recruiting to active, no longer recruiting.
- 05 Nov 2018 Status changed from not yet recruiting to recruiting.